BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Clinical Outcome
8 results:

  • 1. Withaferin A mediated changes of miRNA expression in breast cancer-derived mammospheres.
    Prajapati KS; Shuaib M; Gupta S; Kumar S
    Mol Carcinog; 2022 Sep; 61(9):876-889. PubMed ID: 35770722
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Chemotherapy-induced S100A10 recruits KDM6A to facilitate oct4-mediated breast cancer stemness.
    Lu H; Xie Y; Tran L; Lan J; Yang Y; Murugan NL; Wang R; Wang YJ; Semenza GL
    J Clin Invest; 2020 Sep; 130(9):4607-4623. PubMed ID: 32427586
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Increased Expression of Gankyrin and Stemness Factor Oct-4 are Associated with Unfavorable clinical outcomes and Poor Benefit of Tamoxifen in breast Carcinoma Patients.
    Jahangiri R; Mosaffa F; EmamiRazavi A; Gharib M; Jamialahmadi K
    Pathol Oncol Res; 2020 Jul; 26(3):1921-1934. PubMed ID: 31853860
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nanoparticle Delivery of miR-708 Mimetic Impairs breast cancer Metastasis.
    Ramchandani D; Lee SK; Yomtoubian S; Han MS; Tung CH; Mittal V
    Mol Cancer Ther; 2019 Mar; 18(3):579-591. PubMed ID: 30679387
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. oct4 suppresses IR‑induced premature senescence in breast cancer cells through STAT3- and NF‑κB-mediated IL‑24 production.
    Kim JY; Kim JC; Lee JY; Park MJ
    Int J Oncol; 2018 Jul; 53(1):47-58. PubMed ID: 29749438
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Expression of embryonal stem cell transcription factors in breast cancer: oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
    Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
    Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.
    Elsir T; Edqvist PH; Carlson J; Ribom D; Bergqvist M; Ekman S; Popova SN; Alafuzoff I; Ponten F; Nistér M; Smits A
    Int J Cancer; 2014 Mar; 134(5):1123-31. PubMed ID: 24037901
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.
    Ben-Porath I; Thomson MW; Carey VJ; Ge R; Bell GW; Regev A; Weinberg RA
    Nat Genet; 2008 May; 40(5):499-507. PubMed ID: 18443585
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.